Evotec (EVO)

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

The Evotec SE American Depositary Shares (EVO) stock price today is $3.41, reflecting a -0.29% move since the market opened. The company’s market capitalization stands at $1.21B, with a daily trading volume of $49.81K shares. For investors tracking price trends, Evotec SE American Depositary Shares stock has ranged between $3.40 and $3.50 today. The previous closing price was $3.42.

Ready to get started? Follow the steps below, or read our guide on how to buy Evotec stock on Kraken starting from $10.